Polymyalgia rheumatica and giant cell arteritis following COVID-19 vaccination: Results from a nationwide survey

We conducted a national in-depth analysis including pharmacovigilance reports and clinical study to assess the reporting rate (RR) and to determine the clinical profile of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) in COVID-19-vaccinated individuals. First, based on the French pharm...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Human vaccines & immunotherapeutics 2024-12, Vol.20 (1), p.2334084
Hauptverfasser:	Jarrot, Pierre-André, Mirouse, Adrien, Ottaviani, Sébastien, Cadiou, Simon, Salmon, Jean-Hugues, Liozon, Eric, Parreau, Simon, Michaud, Martin, Terrier, Benjamin, Gavand, Pierre-Edouard, Trefond, Ludovic, Lavoiepierre, Virginie, Keraen, Jeremy, Rekassa, Daniel, Bouldoires, Bastien, Weitten, Thierry, Roche, Damien, Poulet, Antoine, Charpin, Caroline, Grobost, Vincent, Hermet, Marion, Pallure, Magali, Wackenheim, Chloe, Karkowski, Ludovic, Grumet, Pierre, Rogier, Thomas, Belkefi, Nabil, Pestre, Vincent, Broquet, Emilie, Leurs, Amélie, Gautier, Sophie, Gras, Valérie, Gilet, Pierre, Holubar, Jan, Sivova, Nadia, Schleinitz, Nicolas, Durand, Jean-Marc, Castel, Brice, Petrier, Alexandre, Arcani, Robin, Gramont, Baptiste, Guilpain, Philippe, Lepidi, Hubert, Weiller, Pierre-Jean, Micallef, Joelle, Saadoun, David, Kaplanski, Gilles
Format:	Artikel
Sprache:	eng
Schlagworte:	Ad26COVS1 Adult BNT162 Vaccine ChAdOx1 nCoV-19 clinical study Coronavirus COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 vaccination COVID-19 Vaccines - adverse effects giant cell arteritis Giant Cell Arteritis - epidemiology Humans Middle Aged pharmacovigilance Polymyalgia rheumatica Polymyalgia Rheumatica - epidemiology Vaccination - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!